PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Demonstrated antitumor and apoptogenic effects in various cell lines and animal models, including osteosarcoma and Ehrlich solid tumors [PMID:40735766, PMID:32493124].
Reduced fasting blood glucose, HbA1c, and HOMA-IR while enhancing insulin signaling in diabetic mice [PMID:34679681]; attenuated behavioral alterations and testicular oxidative stress in diabetic rats [PMID:31509596].
Significant reduction of adult and larval counts of Trichinella spiralis in mice [PMID:34515021].
Demonstrated hepatoprotective potency against paracetamol-induced toxicity in rats [PMID:38110557] and ameliorative effects on MSG-induced hepatic injury [PMID:33143024].
Investigated for neuroprotective effects in an experimental rat model [PMID:35485570].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35208993 (2022) — Pharmacological Activities of Soursop (Annona muricata Lin.). · Molecules (Basel, Switzerland)
- 2.PMID: 29462271 (2018) — Emerging therapeutic potential of graviola and its constituents in cancers. · Carcinogenesis
- 3.PMID: 9848004 (1998) — Tropical myeloneuropathies revisited. · Current opinion in neurology
- 4.PMID: 37048268 (2023) — Soursop (Annona muricata) Properties and Perspectives for Integral Valorization. · Foods (Basel, Switzerland)
- 5.PMID: 30151067 (2018) — Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review. · Oxidative medicine and cellular longevity